Sterlin et al2 previously showed that potent SARS-CoV-2–neutralizing IgA antibodies are rapidly produced following infection, even before IgG antibodies, although their levels decline and fail to be detected in saliva around 6 months after symptom onset. This evidence concerns the gene CD79A and infection.